1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Respiratory
Diagnostics Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1.
By Type (Instruments and Devices, Assays & Reagents, Services
& Software)
5.2.2.
By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging
Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
5.2.3.
By Disease Indication (Tuberculosis, Asthma, Lung Cancer,
Chronic Obstructive Pulmonary Disease, Others)
5.2.4.
By End-Use (Hospitals and Clinics, Diagnostics Laboratory,
Others)
5.2.5. By Region
5.2.6. By Company (2023)
5.3.
Market Map
5.3.1. By Type
5.3.2. By Test Type
5.3.3. By Disease
Indication
5.3.4. By End-Use
5.3.5. By Region
6. Asia Pacific
Respiratory Diagnostics Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Type
6.2.2. By Test Type
6.2.3. By Disease
Indication
6.2.4. By End-Use
6.2.5. By Country
6.3.
Asia Pacific: Country Analysis
6.3.1. China Respiratory
Diagnostics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Test Type
6.3.1.2.3.
By Disease Indication
6.3.1.2.4.
By End-Use
6.3.2. India Respiratory
Diagnostics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Test Type
6.3.2.2.3.
By Disease Indication
6.3.2.2.4.
By End-Use
6.3.3. Australia
Respiratory Diagnostics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Test Type
6.3.3.2.3.
By Disease Indication
6.3.3.2.4.
By End-Use
6.3.4. Japan Respiratory
Diagnostics Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Type
6.3.4.2.2.
By Test Type
6.3.4.2.3.
By Disease Indication
6.3.4.2.4.
By End-Use
6.3.5. South Korea Respiratory
Diagnostics Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Type
6.3.5.2.2.
By Test Type
6.3.5.2.3.
By Disease Indication
6.3.5.2.4.
By End-Use
7. Europe Respiratory
Diagnostics Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Type
7.2.2. By Test Type
7.2.3. By Disease
Indication
7.2.4. By
End-Use
7.2.5. By
Country
7.3.
Europe: Country Analysis
7.3.1. France Respiratory
Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Test Type
7.3.1.2.3.
By Disease Indication
7.3.1.2.4.
By End-Use
7.3.2. Germany Respiratory
Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Test Type
7.3.2.2.3.
By Disease Indication
7.3.2.2.4.
By End-Use
7.3.3. Spain Respiratory
Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Test Type
7.3.3.2.3.
By Disease Indication
7.3.3.2.4.
By End-Use
7.3.4. Italy Respiratory
Diagnostics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Test Type
7.3.4.2.3.
By Disease Indication
7.3.4.2.4.
By End-Use
7.3.5. United Kingdom
Respiratory Diagnostics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Test Type
7.3.5.2.3.
By Disease Indication
7.3.5.2.4.
By End-Use
8. North America
Respiratory Diagnostics Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Type
8.2.2. By Test Type
8.2.3. By Disease
Indication
8.2.4. By End-Use
8.2.5. By Country
8.3.
North America: Country Analysis
8.3.1. United States
Respiratory Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Test Type
8.3.1.2.3.
By Disease Indication
8.3.1.2.4.
By End-Use
8.3.2. Mexico Respiratory
Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Test Type
8.3.2.2.3.
By Disease Indication
8.3.2.2.4.
By End-Use
8.3.3. Canada Respiratory
Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Test Type
8.3.3.2.3.
By Disease Indication
8.3.3.2.4.
By End-Use
9. South America
Respiratory Diagnostics Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Type
9.2.2.
By Test Type
9.2.3.
By Disease Indication
9.2.4.
By End-Use
9.2.5. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Respiratory
Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Test Type
9.3.1.2.3.
By Disease Indication
9.3.1.2.4.
By End-Use
9.3.2. Argentina
Respiratory Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Test Type
9.3.2.2.3.
By Disease Indication
9.3.2.2.4.
By End-Use
9.3.3. Colombia Respiratory
Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Test Type
9.3.3.2.3.
By Disease Indication
9.3.3.2.4.
By End-Use
10. Middle East and
Africa Respiratory Diagnostics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Type
10.2.2. By Test Type
10.2.3. By Disease Indication
10.2.4. By End-Use
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
Respiratory Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Test Type
10.3.1.2.3.
By Disease Indication
10.3.1.2.4.
By End-Use
10.3.2. Saudi Arabia
Respiratory Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Test Type
10.3.2.2.3.
By Disease Indication
10.3.2.2.4.
By End-Use
10.3.3. UAE Respiratory
Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Test Type
10.3.3.2.3.
By Disease Indication
10.3.3.2.4.
By End-Use
10.3.4. Egypt Respiratory
Diagnostics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Test Type
10.3.4.2.3.
By Disease Indication
10.3.4.2.4.
By End-Use
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Respiratory Diagnostics Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
Competitive Landscape
15.1.
Koninklijke Philips N.V
15.1.1. Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (In case of listed)
15.1.5.
Recent Developments
15.1.6.
SWOT Analysis
15.2. Beckton, Dickson and Company
15.3. Thermo Fisher
Scientific Inc.
15.4. Abbott Laboratories Inc.
15.5. Drägerwerk AG & Co. KGaA
15.6. Siemens Healthineers AG
15.7. PerkinElmer Inc.
15.8. India Medtronic Private Limited
15.9. Bio-Rad Laboratories, Inc.
15.10. GE HealthCare Technologies Inc.
16. Strategic Recommendations
17. About Us & Disclaimer